Davidoff Michael J. 4
4 · Phreesia, Inc. · Filed Jan 31, 2023
Insider Transaction Report
Form 4
Davidoff Michael J.
See Remarks
Transactions
- Sale
Common Stock
2023-01-30$36.26/sh−16,262$589,645→ 108,749 total - Sale
Common Stock
2023-01-31$38.00/sh−3,265$124,082→ 105,484 total - Exercise/Conversion
Common Stock
2023-01-30$8.03/sh+11,378$91,365→ 136,592 total - Exercise/Conversion
Common Stock
2023-01-30$4.71/sh+712$3,354→ 137,304 total - Sale
Common Stock
2023-01-30$35.89/sh−12,293$441,144→ 125,011 total - Exercise/Conversion
Stock Option
2023-01-30−11,378→ 0 totalExercise: $8.03Exp: 2029-01-16→ Common Stock (11,378 underlying) - Exercise/Conversion
Stock Option
2023-01-30−712→ 0 totalExercise: $4.71Exp: 2028-01-30→ Common Stock (712 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to $36.13 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.14 to $36.52 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]This option is fully vested and exercisable as of the date hereof.